MarketPeel
Insider Trading Intelligence
Pricing
…
JH

John B. III Henneman

ANIK
DIRECTOR · ANIKA THERAPEUTICS, INC. · CIK 0001187572
FILING MIX · LIFETIME100%/0%
BUYS
31
SELLS
0
TOTAL VALUE
$465.4K
COMPANIES
3
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
183,602
AVG SELL PX
—
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by John B. III Henneman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+83.33%+9.37%+1.49%+7.89%+8.59%—
14d6+100.00%+7.50%+2.00%+6.87%+7.66%—
30d6+50.00%-1.98%+0.24%-2.18%+3.57%—
60d6(1 pending)+80.00%-0.07%+2.34%-2.40%-0.55%—
90d6(2 pending)+0.00%-14.88%+5.51%-20.38%-24.03%—
180d6(2 pending)+0.00%-32.51%+8.48%-40.99%-47.11%—
1y6(2 pending)+0.00%-55.05%+5.28%-60.33%-65.45%—
2y6(2 pending)+0.00%-74.81%+24.01%-98.82%-117.13%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIK · 65,273 shares · as of Jun 18, 2026
016,31832,63748,95565,273202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 31 buys / 0 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,402——65,273Jun 18, 2026Jun 23, 2026 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,555——12,555Jun 16, 2026Jun 17, 2026 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,135——13,364Jun 16, 2026Jun 17, 2026 ↗View →
OFIX
ORTHOFIX MEDICAL INC.
PURCHASEGRANT
Stock grant
14,965——105,774Jun 10, 2026Jun 12, 2026 ↗View →
OFIX
ORTHOFIX MEDICAL INC.
PURCHASE
5,000$12.26$61.3K90,809May 7, 2026May 8, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
5,000$14.66$73.3K54,871May 1, 2026May 4, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,164——49,871Jun 20, 2025Jun 24, 2025 ↗View →
OFIX
ORTHOFIX MEDICAL INC.
PURCHASEGRANT
Stock grant
18,841——83,706Jun 18, 2025Jun 23, 2025 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,185——4,185Jun 5, 2025Jun 9, 2025 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,045——10,229Jun 5, 2025Jun 9, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,771——35,707Jul 9, 2024Jul 11, 2024 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,185——4,185Jun 20, 2024Jun 21, 2024 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,045——9,184Jun 20, 2024Jun 21, 2024 ↗View →
OFIX
ORTHOFIX MEDICAL INC.
PURCHASEGRANT
Stock grant
15,152$12.87$195.0K63,914Jun 18, 2024Jun 20, 2024 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
3,430——3,430Mar 13, 2024Mar 14, 2024 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
3,430——3,430Mar 13, 2024Mar 14, 2024 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
6,860$7.29$50.0K8,139Mar 13, 2024Mar 14, 2024 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,000——2,000Aug 23, 2023Aug 24, 2023 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
500——1,279Aug 23, 2023Aug 24, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,500——29,936Jun 14, 2023Jun 16, 2023 ↗View →
OFIX
ORTHOFIX MEDICAL INC.
PURCHASEGRANT
Stock grant
14,354——48,762Jan 5, 2023Feb 9, 2023 ↗View →
OFIX
ORTHOFIX MEDICAL INC.
PURCHASEGRANT
Stock grant
14,052——48,460Jan 5, 2023Jan 9, 2023 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,995——15,605Jul 28, 2022Aug 1, 2022 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
29,575——29,575Jul 28, 2022Aug 1, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,954——23,436Jun 8, 2022Jun 10, 2022 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,750——22,750Jun 30, 2021Jul 1, 2021 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,610——9,610Jun 30, 2021Jul 1, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,172——15,482Jun 16, 2021Jun 21, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
2,000$42.86$85.7K11,310May 18, 2021May 20, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,310——9,310Sep 3, 2020Sep 8, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,600——5,600Jun 30, 2020Jul 1, 2020 ↗View →
Other insiders · ANIK
Loading peer insiders…
About this filer
CIK 0001187572
ROLE
Director
PRIMARY
ANIK
COMPANIES
3
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001187572DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback